Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00131521 · ClinicalTrials.gov registry record · NA

Comparison of Different Mucoactive Agents for the Care of the Intubated Patient in a Surgical Trauma Intensive Care Unit

A NA study, sponsored by The University of Texas Health Science Center at San Antonio.

Completed
Registry status
NA
Development phase
260
Enrollment target

NCT00131521 is a NA study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 260 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00131521, a NA study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.

COMPLETED
Registry status
NA
Development phase
260 participants
Enrollment target

Study Summary

This study compares N-acetylcysteine (mucomyst) and sodium chloride to determine their efficacy in the prevention of pulmonary mucus obstruction and retention in intubated patients admitted to the surgical trauma intensive care unit (STICU).

Interventions

  • DRUG mucomyst
  • DRUG sodium chloride (saline)

Trial Details

FieldValue
Enrollment Target 260 participants
Start Date 2005-01
Est. Completion 2007-12
Phase NA

What the Registry Record Tells You About NCT00131521

The ClinicalTrials.gov registry entry for NCT00131521 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which mucomyst is the first listed.

NCT00131521 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00131521 about?

NCT00131521 is a clinical study titled "Comparison of Different Mucoactive Agents for the Care of the Intubated Patient in a Surgical Trauma Intensive Care Unit". This study compares N-acetylcysteine (mucomyst) and sodium chloride to determine their efficacy in the prevention of pulmonary mucus obstruction and retention in intubated patients admitted to the surgical trauma intensive care unit (STICU).

What is the current status of trial NCT00131521?

This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 2005-01. Estimated completion is 2007-12.

What interventions are being tested in trial NCT00131521?

The interventions under investigation include: mucomyst (DRUG), sodium chloride (saline) (DRUG).

Who is sponsoring clinical trial NCT00131521?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.